Efficacy and Safety of mAnnitol in Bowel Preparation During Elective Colonoscopy and Comparison With Moviprep®

NCT04759885 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

886

Enrollment

INDUSTRY

Sponsor class

Conditions

Elective Colonoscopy

Interventions

DRUG: Phase II: NTC015 low dose
DRUG: Phase II: NTC015 medium dose
DRUG: Phase II: NTC015 high dose
DRUG: Phase III: NTC015 selected dose
DRUG: Phase III: Polyethylene glycol plus ascorbate solution (2L PEG ASC)

Sponsor

NTC srl